Baxter is recalling two lots of DIANEAL Low Calcium peritoneal dialysis solution after finding oxidized stainless steel, garment fiber and PVC particles during manufacturing. Such particles can cause local inflammation or adhesions and, with existing peritonitis, could prove fatal.
Section archive
Page 33 of 288
Health News
Drugs, disease, healthcare, government and lifestyle: health news beyond the plate.
- All desks
- Abortion
- Accutane
- Acetaminophen
- Acid Reflux
- Acidic Foods
- Acne
- Acrylamide
- Acupuncture
- Additives
- ADHD
- Adiposity
- Advisories
- Aerobic Exercise
- Aflatoxin
- Agave
- Agent Orange
- Aging
- Agriculture
- AIDS
- Air Pollution
- Airline Passengers
- Airport
- ALA
- Alcohol
- Alcoholic Beverage
- Alerts
- Allergy
- Alli
- Aloe Vera
- ALS
- Alternative Medicine
- Aluminum
- Alzheimer's
- Amalgam
- AMD
- Ampyra
- Amygdala
- Anal Cancer
- And
- Anemia
- Angiogenesis
- Animal Protein
- Animals
- Anorexia
- Anthocyanins
- Anthrax
- Anti-Angiogenesis
- Anti-Obesity
- Antibacterial
- Antibiotic
Miscellaneous
TRICAST Launches New Version of Web-Based Pharmacy Benefits Surveillance and Analytics Software Tool
TRICAST released Reveal 2.0, a web-based tool for pharmacy benefit surveillance and analytics that tracks pricing, process, formulary and rebate adherence and bundles CMS oversight functions. The launch also marks the company's move into software-as-a-service delivery.
Environment
Mobile phones damage male fertility - updated
Sperm samples exposed to mobile phone radiation showed less progressive movement and more DNA fragmentation in a study of 35 healthy men. A separate meta-analysis of ten studies covering 1,492 semen samples found reduced sperm motility and viability but no effect on concentration.
Miscellaneous
Scientist detail urgent research agenda to better understand, address chronic disease toll
Experts at an NIH-sponsored conference say health systems that keep HIV patients alive in low- and middle-income countries need repurposing to treat the chronic diseases those patients now face, from tuberculosis and cancer to kidney disease and diabetes, and urge more research capacity.
Miscellaneous
Disaster-prone APEC economies step up risk-reduction
Senior disaster management officials from APEC economies, meeting in Beijing after the 6.5 magnitude Ludian earthquake, detailed measures to strengthen relief and risk reduction. China's vice minister of civil affairs, Dou Yupei, called frequent disasters a serious threat to the region.
Drug
Drug Information Update - FDA approves Belsomra (suvorexant) to treat insomnia
The FDA approved Belsomra (suvorexant) for insomnia, the first orexin receptor antagonist, in 5, 10, 15 and 20 mg strengths. It is taken once a night within 30 minutes of bed with at least seven hours before waking; drowsiness was the most commonly reported adverse reaction in trials.
Drug
NSAIDs fight breast cancer
A retrospective analysis found that overweight and obese postmenopausal breast cancer patients on hormone therapy who used NSAIDs had half the recurrence rate and more than two extra disease-free years. The investigators call the results preliminary and are running studies to confirm them.
Drug
Clodronate effective in preventing fractures
A University of Siena meta-analysis of 18 trials found patients treated with clodronate had 43 percent lower risk of new vertebral fractures, 33 percent lower risk of non-vertebral fractures and 25 percent lower overall fracture risk than those who did not take it.
Drug
Acetaminophen Overdose Is Far Easier Than You Might Think
Acetaminophen sends more than 80,000 Americans to emergency rooms a year, and the gap between a safe and a harmful dose is narrow: 25 percent above the daily maximum, two extra-strength pills, can damage the liver within a couple of weeks. It appears in more than 600 drugs.
Drug
FDA approves new type of sleep drug, Belsomra
The FDA approved Belsomra (suvorexant), the first orexin receptor antagonist, for trouble falling and staying asleep. It comes in 5, 10, 15 and 20 mg strengths, taken once a night at least seven hours before waking. Drowsiness was the most commonly reported adverse reaction.
Drug
Safety of weight loss drugs
A rundown of anti-obesity drugs: fenfluramine, sibutramine and rimonabant withdrawn over heart valve, cardiovascular and psychiatric harms; orlistat often not tolerated; phentermine and diethylpropion capped at 12 weeks; lorcaserin and phentermine-topiramate approved but untested long term.
Miscellaneous
News from CPSC: ESL, Interlogix Hard-Wired Smoke Alarms Recalled Due to Failure to Alert Consumers of a Fire
About 141,000 ESL and Interlogix 400 and 500 series hard-wired smoke detectors in the U.S., plus 13,000 in Canada, are being recalled because radio frequency interference can keep them from sounding an alarm. They were installed mainly in commercial buildings, schools and hotels.
Miscellaneous
News from CPSC: Public Calendar - 08-13-14
A CPSC notice listing the agency's public calendar for the week of August 18-24, 2014, including staff meetings with outside parties; no Commission briefings or meetings were scheduled that week.
Miscellaneous
Baxter Initiates Voluntary Recall of One Lot of 0.9% Sodium Chloride Injection, USP Intravenous (IV) Solution
Baxter is recalling one lot of 0.9% Sodium Chloride Injection, USP 1000 mL after finding particulate matter near the administration port, which if infused could block blood vessels. No adverse events have been reported, and the lot went to 29 U.S. customers in late February 2014.
Miscellaneous
Broadspire®'s Jacob Lazarovic, M.D. to Present at 2014 WCI Conference
Broadspire chief medical officer Jacob Lazarovic will speak on two panels at the Workers' Compensation Institute conference in Orlando, August 17-20: one on early intervention in chronic pain claims and the biopsychosocial model, the other on collaboration among stakeholders.
Miscellaneous
Freshway Foods Associates Honored at Appreciation Luncheon
Freshway Foods handed out gift cards and a 55-inch television at its monthly associate appreciation luncheon and recognized 5, 10 and 15 years of service. Maintenance associate Mark Redmon became only the second employee to reach 25 years with the company.
Government
FDA Updates for Health Professionals - 08-13-2014
An FDA roundup for health professionals covers the recall of Cubicin injection vials over possible glass particulate and a Class I recall of IPM Wound Gel for bacterial contamination, plus MedWatch reporting resources and an August 28 webinar.
Drug
Metformin impairs cognition in type 2 diabetics
Australian researchers found people with diabetes were 51% more likely than non-diabetics to show worse cognitive performance, and that among diabetics, those treated with metformin were 123% more likely to perform worse than those not on the drug.
5182 stories